InsidersTradesSigma
Track the Cardinal Health share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €54bn. The latest transaction was reported on 8 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Gregory Kenny. All data is accessible without an account.
Analysts rate Cardinal Health Strong Buy (bullish), based on 16 analysts. Average price target: US$270.94.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Cardinal Health is an American company that specializes in the distribution of pharmaceuticals and medical devices. It also provides supply chain management services to healthcare institutions.